Skip to main content
Log in

Comparing chemotherapy options in metastatic pancreatic cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Gharaibeh M, et al. Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer. PharmacoEconomics : 6 Jul 2018. Available from: URL: http://doi.org/10.1007/s40273-018-0684-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Comparing chemotherapy options in metastatic pancreatic cancer. PharmacoEcon Outcomes News 807, 10 (2018). https://doi.org/10.1007/s40274-018-5089-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5089-6

Navigation